Car T Therapy Market Scope And Analysis

  • Report Code : TIPRE00003731
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

CAR-T Therapy Market Scope and Growth by 2031

Buy Now

CAR-T Therapy Market Report CAR-T Therapy Market Size and Share CAR-T Therapy Market Scope and Analysis

CAR-T Therapy Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 16.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Targeted Antigen
  • CD 19
  • BCMA
  • HER2
  • GD2
  • CD 20
  • CD22
  • CD30
  • CD33
  • HER1 and Others
By Therapeutic Application
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Multiple Myeloma
  • Glioblastoma
  • Sarcoma
  • Neuroblastoma
  • Acute Myeloid Leukemia
  • Breast Cancer
  • Pancreatic Cancer
  • Hepatocellular Carcinoma
  • Colorectal Cancer and Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis International AG
  • Kite Pharma Inc Gilead Sciences Inc
  • Juno Therapeutics Celgene Corporation
  • Bluebird Bio Inc Celgene Corporation
  • Sorrento Therapeutics Inc
  • Mustang Bio Inc
  • Aurora Biopharma Inc
  • Legend Biotech Genscript Biotech Corporation
  • Pfizer Inc